Literature DB >> 16534873

Smad3 knock-out mice as a useful model to study intestinal fibrogenesis.

Giuliana Zanninelli1, Antonella Vetuschi, Roberta Sferra, Angela D'Angelo, Amato Fratticci, Maria Adelaide Continenza, Maria Chiaramonte, Eugenio Gaudio, Renzo Caprilli, Giovanni Latella.   

Abstract

AIM: To evaluate the possible differences in morphology and immunohistochemical expression of CD3, transforming growth factor beta1 (TGF-beta1), Smad7, alpha-smooth muscle actin (alpha-Sma), and collagen types I-VII of small and large intestine in Smad3 null and wild-type mice.
METHODS: Ten null and ten wild-type adult mice were sacrificed at 4 mo of age and the organs (esophagus, small and large bowel, ureters) were collected for histology (hematoxylin and eosin, Masson thrichrome, silver staining), morphometry and immunohistochemistry analysis. TGF-beta1 levels of intestinal tissue homogenates were assessed by ELISA.
RESULTS: No macroscopic intestinal lesions were detected both in null and wild-type mice. Histological and morphometric evaluation revealed a significant reduction in muscle layer thickness of small and large intestine in null mice as compared to wild-type mice. Immunohistochemistry evaluation showed a significant increase of CD3+ T cell, TGF-beta1 and Smad7 staining in the small and large intestine mucosa of Smad3 null mice as compared to wild-type mice. Alpha-Sma and collagen I-VII staining of small and large intestine did not differ between the two groups of mice. TGF-beta1 levels of colonic tissue homogenates were significantly higher in null mice than in wild-type mice. In preliminary experiments a significant reduction of TNBS-induced intestinal fibrosis was observed in null mice as compared to wild-type mice.
CONCLUSION: Smad3 null mice are a useful model to investigate the in vivo role of the TGF-beta/Smad signalling pathway in intestinal inflammation and fibrosis.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16534873      PMCID: PMC4124431          DOI: 10.3748/wjg.v12.i8.1211

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  59 in total

1.  TGF-beta/Smad signaling defects in inflammatory bowel disease: mechanisms and possible novel therapies for chronic inflammation.

Authors:  C Fiocchi
Journal:  J Clin Invest       Date:  2001-08       Impact factor: 14.808

2.  The role of Smad3 in mediating mouse hepatic stellate cell activation.

Authors:  B Schnabl; Y O Kweon; J P Frederick; X F Wang; R A Rippe; D A Brenner
Journal:  Hepatology       Date:  2001-07       Impact factor: 17.425

Review 3.  Transforming growth factor-beta signaling through the Smad pathway: role in extracellular matrix gene expression and regulation.

Authors:  Franck Verrecchia; Alain Mauviel
Journal:  J Invest Dermatol       Date:  2002-02       Impact factor: 8.551

4.  Can we influence fibrosis in Crohn's disease?

Authors:  G V Assche
Journal:  Acta Gastroenterol Belg       Date:  2001 Apr-Jun       Impact factor: 1.316

5.  Differential expression of TGF-beta isoforms by normal and inflammatory bowel disease intestinal myofibroblasts.

Authors:  B C McKaig; K Hughes; P J Tighe; Y R Mahida
Journal:  Am J Physiol Cell Physiol       Date:  2002-01       Impact factor: 4.249

6.  Loss of transforming growth factor beta signalling in the intestine contributes to tissue injury in inflammatory bowel disease.

Authors:  K B Hahm; Y H Im; T W Parks; S H Park; S Markowitz; H Y Jung; J Green; S J Kim
Journal:  Gut       Date:  2001-08       Impact factor: 23.059

7.  Blocking Smad7 restores TGF-beta1 signaling in chronic inflammatory bowel disease.

Authors:  G Monteleone; A Kumberova; N M Croft; C McKenzie; H W Steer; T T MacDonald
Journal:  J Clin Invest       Date:  2001-08       Impact factor: 14.808

Review 8.  Transforming growth factor-beta and Smad signalling in kidney diseases.

Authors:  Wansheng Wang; Vijay Koka; Hui Y Lan
Journal:  Nephrology (Carlton)       Date:  2005-02       Impact factor: 2.506

9.  Mice lacking Smad3 are protected against cutaneous injury induced by ionizing radiation.

Authors:  Kathleen C Flanders; Catherine D Sullivan; Makiko Fujii; Anastasia Sowers; Mario A Anzano; Alidad Arabshahi; Christopher Major; Chuxia Deng; Angelo Russo; James B Mitchell; Anita B Roberts
Journal:  Am J Pathol       Date:  2002-03       Impact factor: 4.307

10.  Smad3 deficiency attenuates bleomycin-induced pulmonary fibrosis in mice.

Authors:  Jingsong Zhao; Wei Shi; Yan-Ling Wang; Hui Chen; Pablo Bringas; Michael B Datto; Joshua P Frederick; Xiao-Fan Wang; David Warburton
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2002-03       Impact factor: 5.464

View more
  9 in total

Review 1.  Animal models of intestinal fibrosis: new tools for the understanding of pathogenesis and therapy of human disease.

Authors:  Florian Rieder; Sean Kessler; Miquel Sans; Claudio Fiocchi
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2012-08-09       Impact factor: 4.052

2.  Electrical stimulation of gut motility guided by an in silico model.

Authors:  Bradley B Barth; Craig S Henriquez; Warren M Grill; Xiling Shen
Journal:  J Neural Eng       Date:  2017-12       Impact factor: 5.379

Review 3.  TGF-β signal transduction pathways and osteoarthritis.

Authors:  Guangju Zhai; Jules Doré; Proton Rahman
Journal:  Rheumatol Int       Date:  2015-03-15       Impact factor: 2.631

4.  Infection with enteric pathogens Salmonella typhimurium and Citrobacter rodentium modulate TGF-beta/Smad signaling pathways in the intestine.

Authors:  Yong-Guo Zhang; Megha Singhal; Zhijie Lin; Christopher Manzella; Anoop Kumar; Waddah A Alrefai; Pradeep K Dudeja; Seema Saksena; Jun Sun; Ravinder K Gill
Journal:  Gut Microbes       Date:  2018-03-27

5.  Smad3 knockout mice exhibit impaired intestinal mucosal healing.

Authors:  Cheri R Owen; Lisi Yuan; Marc D Basson
Journal:  Lab Invest       Date:  2008-08-18       Impact factor: 5.662

6.  Cellular and molecular mechanisms of intestinal fibrosis.

Authors:  Silvia Speca; Ilaria Giusti; Florian Rieder; Giovanni Latella
Journal:  World J Gastroenterol       Date:  2012-07-28       Impact factor: 5.742

7.  Localization of ανβ6 integrin-TGF-β1/Smad3, mTOR and PPARγ in experimental colorectal fibrosis.

Authors:  G Latella; A Vetuschi; R Sferra; S Speca; E Gaudio
Journal:  Eur J Histochem       Date:  2013-12-04       Impact factor: 3.188

8.  Transforming growth factor-beta/Smad3 signalling regulates inflammatory responses in a murine model of contact hypersensitivity.

Authors:  M Anthoni; N Fyhrquist-Vanni; H Wolff; H Alenius; A Lauerma
Journal:  Br J Dermatol       Date:  2008-07-04       Impact factor: 9.302

Review 9.  Cellular and Molecular Mediators of Intestinal Fibrosis.

Authors:  Ian C Lawrance; Gerhard Rogler; Giorgos Bamias; Christine Breynaert; Jon Florholmen; Gianluca Pellino; Shimon Reif; Silvia Speca; Giovanni Latella
Journal:  J Crohns Colitis       Date:  2017-12-04       Impact factor: 9.071

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.